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Oxidative stress is thought to be one of the main mediators of neuronal damage in human neurode-
generative disease. Still, the dissection of causal relationships has turned out to be remarkably difﬁcult.
Here, we have analyzed global protein oxidation in terms of carbonylation of membrane proteins and
cytoplasmic proteins in three different mammalian species: aged human cortex and cerebellum from
patients with or without Alzheimer's disease, mouse cortex and cerebellum from young and old animals,
and adult rat hippocampus and cortex subjected or not subjected to cerebral ischemia. Most tissues
showed relatively similar levels of protein oxidation. However, human cortex was affected by severe
membrane protein oxidation, while exhibiting lower than average cytoplasmic protein oxidation. In
contrast, ex vivo autooxidation of murine cortical tissue primarily induced aqueous protein oxidation,
while in vivo biological aging or cerebral ischemia had no major effect on brain protein oxidation. The
unusually high levels of membrane protein oxidation in the human cortex were also not predicted by
lipid peroxidation, as the levels of isoprostane immunoreactivity in human samples were considerably
lower than in rodent tissues. Our results indicate that the aged human cortex is under steady pressure
from speciﬁc and potentially detrimental membrane protein oxidation. The pronounced difference be-
tween humans, mice and rats regarding the primary site of cortical oxidation might have contributed to
the unresolved difﬁculties in translating into therapies the wealth of data describing successful anti-
oxidant neuroprotection in rodents.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Oxidative stress and redox dysregulation are biochemical
characteristics of aging and many neurodegenerative disorders [1–
4]. For instance, increased steady-state levels of oxidative end
products have been reported for the majority of neurodegenera-
tive diseases. However, only few of the clinical studies pursuing
antioxidant regimens have ended with a positive outcome, and the
beneﬁt was usually modest [2,5]. Thus, it is possible that some of
the functionally relevant targets of oxidation in these diseases are
still to be discovered.
The potential biochemical victims of redox failure in the aged
or injured human brain are diverse. Results from post-mortem
studies have indicated that in Alzheimer's disease, above-normal
levels of oxidation in proteins can occur on soluble proteins as wellB.V. This is an open access article u
d Redox Medicine, Institute
the Johannes Gutenberg Uni-
smann).as protein ﬁlaments and aggregates [6]. Various side chains as well
as the protein backbone may be affected. Speciﬁcally, protein
tyrosine nitration [7], dityrosine formation [7], glycoxidation [8]
and protein carbonyl accumulation [9,10] have been described.
Moreover, signiﬁcant damage to nucleic acids has been demon-
strated [10–12]. Notably though, effect sizes in many of these in-
vestigations have been relatively small [9,10].
Integral membrane proteins have rarely been studied as sepa-
rate entity in brain protein oxidation studies, despite the fact that
various observations indicate a special role for these proteins as
targets of oxidation. For instance, membrane proteins of the inner
mitochondrial membrane massively accumulate the antioxidant
amino acid methionine as a means of autoprotection [13], whereas
other redox-active amino acids are avoided in an oxygen usage-
dependent manner [14,15]. In senescence accelerated-prone mice,
spin labeling studies have indicated a selective, oxidative stress-
induced alteration of synaptosomal membrane protein structure
[16]. Moreover, model studies in vitro [17] and in cultivated cells
[18,19] have suggested the occurrence and relevance of one-elec-
tron transfer reactions from within the lipid bilayer onto thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
M. Granold et al. / Redox Biology 4 (2015) 200–207 201lateral surfaces of the embedded membrane proteins. After all, the
fact that only lipophilic antioxidants show relevant neuroprotec-
tive capacity in cell culture [19–21] might not only be due to their
selective prevention of lipid peroxidation, but also due to their
selective prevention of integral membrane protein oxidation.
Hence, we have investigated the extent of membrane protein
oxidation in neural tissues from mice, rats, and humans, in order
to achieve a basic characterization of its occurrence in the central
nervous system.Materials and methods
Human Alzheimer's disease tissue
Post-mortem tissue samples from neocortex and cerebellum of
three non-demented individuals (Hu1–Hu3) and three Alzheimer's
disease patients (Hu4–Hu6) were obtained from the Brain Bank of
the Paul Flechsig Institute for Brain Research at the University of
Leipzig. The diagnosis of deﬁnite Alzheimer's disease was based on
the presence of neuroﬁbrillary tangles and neuritic plaques in
hippocampus and neocortex and met the criteria of the National
Institute on Aging (NIA) and the Consortium to Establish a Registry
for Alzheimer's Disease (CERAD) [22]. All cortical tissues were
from Brodman area 22 of the temporal lobe. Alzheimer's disease
cases were Braak stage V/VI, controls were either free of dis-
cernible neuropathological changes or possessed only a few iso-
lated neuroﬁbrillary tangles [23]. Terminal cause of death was
bronchopneumonia in all cases. Further diagnoses and post mor-
tem intervals (PMI) were: Hu1: age 78 y, male, PMI 24 h; nicotine
abuse, arteriosclerosis. Hu2: age 84 y, female, PMI 36 h; chronic
alcoholism. Hu3: age 82 y, male, PMI 46 h; arteriosclerosis. Hu4:
age 69 y, male, PMI 40 h. Hu5: age 64 y, female, PMI 32 h. Hu6: age
88 y, female, PMI 48 h. Regarding the potential inﬂuence of the
additional diagnoses in the non-demented individuals on brain
protein oxidation, no data from human samples seem to exist.
Consideration of plasma markers indicates that chronic alcohol
abuse might be associated with elevated protein oxidation,
whereas smoking appears to have a minor effect at most [24]. In
rodent models, all conditions have been linked with variable
manifestations of oxidative stress in the periphery. However, ma-
jor effects on the brain have not been reported.
Mouse aging cohort
A cohort of C57BL/6J mice was established and aged under
standard animal care conditions. After weaning, male and female
animals were caged separately in groups of maximum 5 litter-
mates per cage, with free access to food and water, residing in
temperature-, humidity-, and light-controlled rooms (12 h light/
dark cycle). Young (Ms1–Ms3) and old (Ms4–Ms9) mice were
caged individually 1 week before sacriﬁce by cervical dislocation.
The removed brains were ﬂash-frozen in isopentane/dry ice,
wrapped in paraﬁlm, individually placed in small plastic boxes and
thereupon stored at 80 °C. To match the human tissues analyzed,
cortex and cerebellum were chosen for the determination of
membrane protein oxidation. Animal parameters were: Ms1: age
152 d, male, weight 27 g. Ms2: age 150 d, male, weight 30 g. Ms3:
age 150 d, female, weight 27 g. Ms4: age 651 d, male, weight 34 g.
Ms5: age 642 d, female, weight 26 g. Ms6: age 808 d, female,
weight 28 g. Ms7: age 794 d, male, weight 34 g. Ms8: age 651 d,
female, weight 27 g. Ms9: age 651 d, male, weight 34 g.
Bilateral carotid artery occlusion (BCAO) in rats
BCAO with hemorrhagic hypotension was applied to male, 10–12 week old Sprague–Dawley rats as described [25]. After 2 h, the
animals were sacriﬁced, and the anatomical regions of interest
were dissected and frozen at 80 °C. As only the hippocampus is
selectively affected by cell loss in this model of cerebral ischemia,
cortex and hippocampus (in lieu of cerebellum) were further
processed for biochemical analysis. Non-ischemic, naive rats (R1–
R3) of the same cohort were used as controls for the cerebral
ischemia rats (R4–R7).
Membrane protein preparation
Human, mouse and rat brain samples were fractionated by
differential centrifugation. Samples of 100–200 mg were
homogenized on ice with a Potter-Elvehjem apparatus in 6 vo-
lumes of buffer A, containing 5 mM TRIS pH 7.4, 1 mM EDTA, 1 mM
DTT, 10 mM phenothiazine, and 1 protease inhibitor cocktail
(Sigma-Aldrich). Following 60 passages through a 25-gauge needle
and brief sonication (35 s), the homogenate was mildly cen-
trifuged (800g for 10 min at 4 °C) to remove any protein ag-
gregates and insoluble material. The supernatant was then ultra-
centrifuged (100,000g for 90 min at 4 °C) to generate membrane
(pellet) and cytoplasmic (supernatant) fractions, which were
quality controlled by Western blotting against the marker proteins
Naþ/Kþ-ATPase (ATP1A1) and superoxide dismutase (SOD1) using
monoclonal antibodies (anti-Naþ/Kþ-ATPase α1 subunit from
Novus Biologicals, 1:1000; anti-SOD1 from Epitomics, 1:1000). A
selection of human and rat brain samples were also fractionated
by phase separation with Triton X-114 [26], yielding similar re-
sults. Protein contents of all obtained fractions were determined
using the bicinchoninic acid method (Pierce), which was compa-
tible with the employed buffer and reagent concentrations.
Protein carbonyl immunoblotting
Protein carbonyls were quantiﬁed by derivatization with 2,4-
dinitrophenyl hydrazine (DNPH). Subcellular fractions containing
8 mg protein were adjusted to identical volume with buffer A,
supplemented with 0.5 volumes of buffer B (180 mM TRIS pH 7.4,
30% sucrose, 6% SDS), mixed, and incubated with 0.5 volumes of
freshly prepared DNPH derivatization solution (10 mM DNPH in
2 M HCl) for 20 min at room temperature. After neutralization
with 0.33 volumes of 3 M TRIS base, the samples were supple-
mented with 0.33 volumes of loading buffer (200 mM TRIS pH 6.8,
40% glycerol, 20% β-mercaptoethanol, 8% SDS, 0.04% bromophenol
blue), separated by SDS-PAGE in a 10% gel (acrylamide:bis-acry-
lamide 29:1) and transferred onto nitrocellulose membranes fol-
lowing standard protocols. After 1 h incubation with 5% fat-free
dry milk in TBST, the membranes were probed with anti-2,4-di-
nitrophenyl (anti-DNP) antibody (1:1000; from Invitrogen) in TBST
at 4 °C overnight. The membranes were washed three times with
TBST, incubated for 1.5 h with peroxidase-conjugated donkey anti-
rabbit antibody (1:10,000; from Jackson Immunoresearch) at room
temperature, washed three times with TBST again, and visualized
by enhanced chemiluminescence. Ponceau staining (0.1% Ponceau
S in 5% acetic acid) of the blots was performed as loading control.
Anti-isoprostane enzyme immunoassay
The levels of anti-isoprostane immunoreactivity were de-
termined by competitive enzyme immunoassay (Cayman Chemi-
cal), employing an antiserum that has been shown to be speciﬁc
for 8-iso prostaglandin F2α against a considerable number of likely
competitors (http://www.caymanchem.com/catalog/516351). Still,
it cannot be excluded that it may have cross-reacted with oxidized,
isoprostane-like derivatives of fatty acids other than arachidonic
acid, particularly docosahexaenoic acid, which is an abundant, but
M. Granold et al. / Redox Biology 4 (2015) 200–207202rather evenly distributed component of the brain [27]. Hence, the
obtained data are presented as relative immunoreactivities per
unit of membrane protein rather than absolute 8-iso prostaglandin
F2α concentrations.
Experimental design and statistical analysis
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Fig. 1. Protein oxidation in human cortex and cerebellum. (A) Cortical and (B) cereb
Alzheimer's disease patients (Hu4–Hu6) were separated by centrifugation into cytoplasm
using an anti-DNP antibody. The numbers in the margin indicate molecular weights (kD
and the cytoplasmic marker superoxide dismutase (SOD1). The bar graphs represent a
membrane proteins were signiﬁcantly more oxidized than cytoplasmic proteins (upper
each tissue). Signiﬁcance levels obtained by post-hoc analysis for the non-demented anmembrane protein oxidation versus cytoplasmic protein oxidation
in the brain of three mammalian species, i.e. human, mouse, and
rat, with each species being represented by two anatomically
distinct central nervous system tissues. Exploratory, secondary
objectives of the current study were post-hoc analyses of probable
sources of variation within each mammalian species, i.e. the po-
tential role of central nervous system disease in the human sam-
ples, the potential role of age in the mouse samples, and thePr
ot
ei
n 
ox
id
at
io
n 
(%
)
0
50
100
150
200
250
300
Pr
ot
ei
n 
ox
id
at
io
n 
(%
)
0
50
100
150
200
Cerebellum
A
nt
i-D
N
P
C M
p = 0.003 (n = 6)
Hu1 Hu2 Hu3 Hu4 Hu5 Hu6
C M C M C M C M C M C M
130
100
70
55
45
35
SOD1
ATP1A1
C M C M
Alzheimer‘s diseaseNon-demented
p = 0.04 / p = 0.5 (n.s.)
p = 0.1 (n.s.) / p = 0.007
ellar tissue samples from three non-demented individuals (Hu1–Hu3) and three
ic (C) and membrane (M) fractions and analyzed by derivatization-Western blotting
a). Parallel blots were probed for the membrane marker Naþ/Kþ-ATPase (ATP1A1)
quantiﬁcation of the anti-DNP immunoreactivity. In both cortex and cerebellum,
panels: po0.001 for cortex, p¼0.003 for cerebellum by two-way ANOVA; n¼6 for
d Alzheimer's disease subgroups are given in the ﬁgure (lower panels).
M. Granold et al. / Redox Biology 4 (2015) 200–207 203potential role of an ischemic lesion in the rat samples. All data
were evaluated by two-way ANOVA (for the primary analysis of
categorical variables) followed by Holm-Sidak's post-hoc test (for
exploratory subgroup analysis); p values of 0.05 or less were
considered signiﬁcant. All data are given as mean7standard
deviation.
Ethical standards
Human brain samples were obtained from the Brain Bank of
the Paul Flechsig Institute for Brain Research at the University of
Leipzig in accordance with the legal and institutional regulations
under which it operates. Regarding animal housing and experi-
mentation, appropriate procedures were used following the in-
stitutional guidelines of the Central Animal Facility of the Uni-
versity of Mainz, and approval was obtained in accordance with
federal law.Results
Membrane protein oxidation in human samples
To investigate whether membrane proteins were relevant tar-
gets of oxidation in the aged human brain, we have analyzed
frozen post mortem tissue samples (n¼6) from neocortex (su-
perior temporal gyrus) and cerebellum, encompassing three Alz-
heimer's disease cases (AD) and three age-matched, non-de-
mented individuals (ND). Protein carbonylation was chosen as
index of oxidation because it reﬂects different types of oxidativePr
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Fig. 2. Protein oxidation in mouse cortex and cerebellum. (A) Cortical and (B) cerebella
analyzed for membrane (M) and cytoplasmic (C) protein oxidation as in Fig. 1. In cerebell
(p¼0.002 by two-way ANOVA; n¼7). In cortex, no statistically signiﬁcant difference wainsults, can be detected with high sensitivity by derivatization-
Western blotting, and appears to be largely irreversible [28,29].
We have found that in both brain regions, membrane proteins
were signiﬁcantly more affected by carbonylation and thus oxi-
dative damage than cytoplasmic proteins (Fig. 1). This effect was
more pronounced in cortex than in cerebellum, as evidenced by
the calculated membrane/cytoplasm (M/C) oxidation ratios (cor-
tex: 47; cerebellum: 2.4). Moreover, a trend towards higher
membrane protein oxidation in Alzheimer's disease samples ver-
sus non-demented individuals was noted (cortex: 138%; cere-
bellum: 142%).
Membrane protein oxidation in mouse samples
Mice are the most widely employed species to model human
neurological diseases associated with oxidative stress. Hence, it
was investigated whether the apparently high levels of membrane
protein carbonylation in the human cortex might also be detected
in mice. As an effect of aging on protein carbonyl content has been
described for a variety of settings [28], the aspect of age was ex-
plored as a potential source of variation. Thus, a cohort of C57BL/6J
mice was grouped into categories young (aged 150 d) and old
(aged 720 d; details are given in the materials and methods) and
tested for brain protein oxidation. The analysis of cortical and
cerebellar membrane and cytoplasmic fractions (n¼7) shown in
Fig. 2 indicates that mouse cortex did not exhibit any bias towards
membrane protein oxidation as observed in the human cortical
samples. In cerebellum, though, mouse samples resembled human
samples in terms of their M/C oxidation ratio. However, there was
no signiﬁcant effect of age on carbonyl content throughout. In allPr
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Fig. 3. Inﬂuence of sample origin and sample handling on protein oxidation. (A) Cross-comparison of protein oxidation in four samples chosen as calibration benchmarks.
The same, indicated samples as analyzed in Figs. 1 A, B and 2 A, B were blotted side by side and quantiﬁed to enable a direct comparison of the full blots. (B) Quantiﬁcation of
protein oxidation in human and mouse tissues based on two calibration blots as in (A). The abbreviations Y and O denote young and old animals, respectively. ND, non-
demented individuals; AD, individuals with Alzheimer's disease. (C) Inﬂuence of storage conditions on protein oxidation in dissected cortices. Cortical quarters from two old
mice (Ms8–Ms9) were frozen at 80 °C or incubated for 48 h at the indicated temperatures in air-exposed TBS before analyzing cytoplasmic (C) and membrane (M) fractions
for anti-DNP immunoreactivity. (D) Quantiﬁcation of the results depicted in (C). Protein oxidation was strongly associated with storage temperature (p¼0.005 by two-way
ANOVA; n¼4). In the post-hoc analysis, this effect was attributable to the cytoplasmic fractions; subgroup p values are indicated in the ﬁgure. Differences at each tem-
perature were statistically insigniﬁcant.
M. Granold et al. / Redox Biology 4 (2015) 200–207204fractions, human and murine, signiﬁcant immunoreactivity was
exclusively detected in proteins with molecular weights higher
than 45 kDa. Interestingly, some of the most intensely stained
bands (at 45 and 55 kDa) in young cortical fractions were
largely absent in the two “oldest old” animals (Ms6 and Ms7;
Fig. 2A).
Effect of species, brain region, and sample storage on membrane
protein oxidation
The large oxidation bias in the human cortical samples (Fig. 1A)
could basically be attributable to an increased membrane signal, or
to a decreased cytoplasmic signal. To distinguish these alternatives
and to achieve a global comparison between brain regions and
animal species, calibration blots were performed with selected
samples already analyzed in Figs. 1 and 2. A representative result is
shown in Fig. 3A. Image quantiﬁcation data from duplicate blots
were used to calculate calibration factors, by which the cross-comparison of all subgroups shown in Fig. 3B was generated. The
result suggests that human cortical samples are unusual in both
respects, high membrane protein oxidation, and low cytoplasmic
protein oxidation. In contrast, cerebellar samples were very simi-
larly affected by protein oxidation in mice and humans. In order to
assess the potential inﬂuence of post mortem handling on these
results, oxidative and elevated temperature storage experiments
with aged mouse cortices were performed. Incubation of cortex
quarters for 2 d in air-exposed TBS at room temperature resulted
in mildly elevated cytoplasmic protein oxidation, whereas mem-
brane proteins were not affected (Fig. 3C and D). Incubation at
37 °C, however, led to pronounced protein oxidation, particularly
in the cytoplasmic fractions. Thus, the absence of cytoplasmic
oxidation in the human cortical samples strongly argues against
any post mortem etiology of the observed high membrane protein
oxidation, together with several other observations reconsidered
in the discussion.
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Fig. 4. Protein oxidation in rat hippocampus and cortex. (A) Cortical and (B) hippocampal tissue samples from three naive (R1–R3) and four ischemic (R4–R7) rats were
separated into cytoplasmic (C) and membrane (M) fractions and analyzed by Western blotting. In both brain regions, cytoplasmic proteins and membrane proteins were
similarly affected by protein oxidation.
M. Granold et al. / Redox Biology 4 (2015) 200–207 205Membrane protein oxidation in rat samples
To investigate whether the second most important model
species in clinical neuroscience, rats, were more predictive of the
human situation, cortical and hippocampal tissues from Sprague–
Dawley rats were analyzed for membrane and cytoplasmic protein
oxidation. Since perimortal inﬂuences and acute lesional effects
due to cerebral ischemia or trauma might have an impact on ir-
reversible markers of oxidation, a subgroup of these animals was
subjected to bilateral carotid artery occlusion with hemorrhagic
hypotension 2 h prior to tissue sampling. As shown in Fig. 4, rats
closely resembled mice in terms of an approximately equal level of
protein oxidation in cytoplasmic and membrane cortical fractions
(n¼7), even if there was a trend towards higher oxidation of
membrane proteins in ischemic samples (ischemic/native: 151%).
In the hippocampus, which was analyzed instead of cerebellum in
this experiment because it is severely affected by neurodegen-
eration under the employed ischemia protocol [25], no statistically
signiﬁcant differences between fractions or treatments could be
detected. These data strengthen the idea that the observed pat-
terns of oxidation in the human cortex indeed mirror physiological
variables established prior to the event of death.
Relationship between membrane protein oxidation and lipid
peroxidation
The deﬁning characteristic of membrane proteins is their em-
bedment into the lipid bilayer. To test whether membrane protein
oxidation was predictable from more established markers of oxi-
dation in the lipid bilayer, lipid peroxidation was quantiﬁed in
terms of the detectable anti-isoprostane immunoreactivity in themembrane fractions already analyzed in Figs. 1, 2, and 4. The result
depicted in Fig. 5 demonstrates that there was at least no simple
correlation between these two markers. Human samples were by
far less affected by lipid peroxidation than rodent samples
(Fig. 5A). The extent of the difference in cortex was approximately
the same as in plasma samples reported individually in the lit-
erature (human: 100–300 pg/ml [30]; rat: 500 pg/ml [31];
mouse: 1500 pg/ml [32]; all samples had been analyzed by ca-
librated GC–MS or LC-MS). Dividing the relative level of membrane
protein oxidation (Fig. 3B) by the relative level of lipid peroxida-
tion (Fig. 5A), human samples from both cortex and cerebellum
turned out to be about 20- to 40-fold more affected by membrane
protein oxidation than the corresponding mouse tissues (Fig. 5B).Discussion
In this study, we have found that membrane proteins in the
human brain are selectively affected by oxidation. Speciﬁcally,
samples from the aged cerebral cortex exhibited severe membrane
protein oxidation, which was accompanied by unusually low levels
of cytoplasmic protein oxidation and lipid peroxidation (Figs. 1A,
3B, and 5A).
It is unlikely that the observed membrane protein oxidation
bias in the human cortical samples is to a signiﬁcant degree at-
tributable to the post-mortem character of these tissues, for six
reasons. (i) There was no correlation between the extent of
membrane protein oxidation and post-mortem interval (PMI data
are given in the materials and methods). (ii) Only cortical samples
were more heavily oxidized than corresponding mouse samples.
Human cerebellar samples exhibited the same degree of
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bellar samples (Fig. 3B). (iii) Prolonged incubation of mouse cor-
tices under oxidative conditions, in air-exposed TBS for 48 h at
room temperature, did not induce membrane protein oxidation
(Fig. 3D). (iv) At an elevated temperature of 37 °C, though, 48 h
incubation did result in increased protein oxidation. However,
cytoplasmic proteins were at least equally affected as membrane
proteins (Fig. 3D). Still, the authentic human samples had been
essentially devoid of cytoplasmic protein oxidation (Fig. 3B).
(v) Incubation of mouse cortices for 48 h in a potentially more
realistic, less oxidative body ﬂuid mimetic, air-exposed serum
(FCS), led to an apparent reduction of membrane protein oxidation
by 10% at room temperature, and by 40% at 37 °C (data not
shown). Thus, protein carbonylation appears to be a rather stable
marker of oxidation even post mortem, which is in agreement
with many previous studies [10,33,34]. (vi) The level of lipid per-
oxidation in the human samples was still much lower than in
immediately frozen, but otherwise corresponding material from
mouse or rat (Fig. 5A).
The origins of the higher steady-state levels of protein carbo-
nylation in membrane proteins call for an explanation. Visibly,
membrane proteins could be more exposed to carbonylating pro-
ducts of lipid peroxidation, such as 4-hydroxynonenal, mal-
ondialdehyde, or acrolein. However, the latter compounds are
readily soluble in water, and experimental studies have indicated
that even the most lipophilic of the mentioned agents, 4-hydro-
xynonenal, primarily reacts with cytoplasmic proteins [35]. Sec-
ond, the transmembrane domains of membrane proteins might be
sterically inaccessible to oxidized protein repair enzymes [13]. In
general, though, protein carbonylation is thought to be irreversible
and thus not subject to repair [29]. Third, the speciﬁc amino acid
composition of transmembrane domains with their ample tyrosine
and tryptophan residues could make these proteins particularly
accessible to one-electron oxidation from within the lipid bilayer
[18,19]. If unrepaired [17,36], these radicalized side chains could
convert into DNPH-reactive quinones [37], or they might dissipate
by attacking neighboring lysine residues or other susceptible
moieties, transforming them into carbonyl end products [19,38]. At
present, though, none of these structural explanations appears to
be fully satisfactory, as they should all apply to human, mouse, and
rat membrane proteins to a basically similar extent.As a more dynamic explanation, it is well possible that mem-
brane proteins with their generally longer lifetimes, especially so
in the brain [39,40], simply accumulate more irreversible damage
before ﬁnally being degraded. Intriguingly, this effect could be
much more pronounced in the large human neocortex, in which
the site of synthesis, site of function, and site of degradation of a
protein are generally much more distant than in smaller brains
[41]. Unfortunately, we are unaware of any experimental de-
termination of protein lifetimes in the human brain. Regarding the
unusually low levels of cytoplasmic protein oxidation in the hu-
man cortex, these proteins might proﬁt more than membrane
proteins from enhanced enzymatic antioxidant defenses, which
tend to be considerably more active in the larger brains of longer-
lived animals [42]. For example, catalase and manganese super-
oxide dismutase have been found to be more than 3-fold more
active in cow or deer brain than in mouse or rat brain [42]. Most
likely, a related effect also accounts for the low level of lipid per-
oxidation observed in human tissues.
In accordance with earlier investigations [8–10], we have seen
only a mild increase in protein carbonylation in Alzheimer's dis-
ease (Fig. 1). Nevertheless, membrane protein oxidation might still
be of critical importance for this and maybe other neurodegen-
erative conditions, as justiﬁed in the following. The conventional
argument to implicate oxidative stress in neurodegeneration has
usually been that steady-state levels of markers of oxidation were
higher in tissue from affected patients than in control tissue. In
slowly progressing diseases, though, this criterion might selec-
tively point to markers of oxidation that are precisely not causally
involved in the disease process. Why should this be the case? As
neurodegeneration proceeds only very slowly in a progressive
disorder like Alzheimer's disease, even in its later stages [43],
there is only very little irreversible degeneration going on at any
given point in time. Hence, the observed steady-state increase of
the incriminated marker is apparently rather well tolerated by the
brain. In contrast, unusually high levels of permanent baseline
oxidation due to largely ﬁxed anatomical, structural or metabolic
circumstances speciﬁc to the human brain might be much more
predictive of impending neurodegeneration. In these cases, even
minor increases atop an already high baseline might move a sy-
napse or neuron across the catastrophic threshold, generally fol-
lowed by the rapid degradation of the collapsed structure by
M. Granold et al. / Redox Biology 4 (2015) 200–207 207autophagy or glial cells. Hence, the very event that had triggered
the catastrophe would have also secured its own disappearance,
disabling its detection in steady-state comparisons. Hence, we
believe that comparative investigations into the baseline levels of
oxidation in young and healthy tissues might offer unconventional
insight into the pathogenesis of neurodegeneration. In particular,
the exploration of membrane protein oxidation as a separate and
potentially autonomous manifestation of oxidative stress seems
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